Skip to main content

Table 3 Post-treatment patient characteristics

From: The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Characteristics

All patients 23 (100%)a

NR 7 (30%)

PR 10 (43%)

TR 6 (26%)

p valueb

Tumor diff. after treatment

    

0.064

 No surgery

3 (13)

0

0

3 (50)

 

 Missing value

5 (22)

2 (29)

1 (10)

2 (33)

 

 Well

5 (22)

1 (14)

4 (40)

0

 

 Moderately

9 (39)

3 (43)

5 (50)

1 (17)

 

 Undifferentiated

1 (4)

1 (14)

0

0

 

Post-treatment stage

    

3.3e−08

 0

6 (26)

0

0

6 (100)

 

 I

7 (30)

0

7 (70)

0

 

 IIA

3 (13)

2 (29)

1 (10)

0

 

 IIIA

2 (9)

0

2 (20)

0

 

 IIIB

2 (9)

2 (29)

0

0

 

 IIIB–IIIC

3 (13)

3 (43)

0

0

 

ypT

    

4.6e−08

 T0

6 (26)

0

0

6 (100)

 

 T1

3 (13)

0

3 (30)

0

 

 T2

6 (26)

0

6 (60)

0

 

 T3

7 (30)

6 (86)

1 (10)

0

 

 T4

1 (4)

1 (14)

0

0

 

PNI

    

1

 +

2 (9)

1 (14)

1 (10)

0

 

 −

21 (91)

6 (86)

9 (90)

6 (100)

 

LVI

    

0.002

 +

8 (35)

6 (86)

2 (20)

0

 

 −

15 (65)

1 (14)

8 (80)

6 (100)

 
  1. LVI lymphovascular invasion, NR non-responders, PNI perineural invasion, PR partial responders, TR total responders, ypT post-treatment tumor
  2. aFirst number: number of patients; number in parentheses: percentage of patients
  3. bThe p value is obtained by Fisher’s exact test and is considered significant when p value < 0.05